Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Uchida

Showing results (11-20 of 512) with videos related to

Pageof 52
Sort By:
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Clinical significance of autologous tumor killing (ATK) activity and its induction therapy in human cancerA Uchida
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1987
[Production and function of the monocyte cytotoxic factor (MCF)]A Uchida
Environmental Health Perspectives|August 1, 1979
Radiation-induced nondisjunctionI A Uchida
Respiratory Care|October 3, 2009
Late presentation of double aortic arch in school-age children presumed to have asthma: the benefits of spirometry and examination of the flow-volume curveDerek A Uchida
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432]T Hoshino, A Uchida
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Limb salvage surgery for pelvic malignancies followed by reconstruction with hip endoprosthesis]H Hamada, A Uchida
International Journal of Cancer|October 15, 1980
Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapyA Uchida, T Hoshino
International Journal of Cancer|January 15, 1983
Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cellsA Uchida, M Micksche
Immunology Letters|January 1, 1985
Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factorsA Uchida, E Klein
Journal of the National Cancer Institute|March 1, 1986
Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytesA Uchida, E Klein
Pageof 52

Showing results (11-20 of 512) with videos related to

Sort By:
Pageof 52
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Clinical significance of autologous tumor killing (ATK) activity and its induction therapy in human cancerA Uchida
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1987
[Production and function of the monocyte cytotoxic factor (MCF)]A Uchida
Environmental Health Perspectives|August 1, 1979
Radiation-induced nondisjunctionI A Uchida
Respiratory Care|October 3, 2009
Late presentation of double aortic arch in school-age children presumed to have asthma: the benefits of spirometry and examination of the flow-volume curveDerek A Uchida
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432]T Hoshino, A Uchida
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Limb salvage surgery for pelvic malignancies followed by reconstruction with hip endoprosthesis]H Hamada, A Uchida
International Journal of Cancer|October 15, 1980
Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapyA Uchida, T Hoshino
International Journal of Cancer|January 15, 1983
Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cellsA Uchida, M Micksche
Immunology Letters|January 1, 1985
Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factorsA Uchida, E Klein
Journal of the National Cancer Institute|March 1, 1986
Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytesA Uchida, E Klein
Pageof 52